Chicago, IL, United States of America

Priscilla S Briquez

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Priscilla S Briquez: Innovator in Wound Treatment and Melanoma Research

Introduction

Priscilla S Briquez is a notable inventor based in Chicago, IL (US). She has made significant contributions to the fields of wound treatment and cancer research through her innovative patents. With a total of 2 patents, her work addresses critical medical needs.

Latest Patents

One of her latest patents is titled "Methods and compositions for the treatment of wounds." This invention provides peptides and polypeptides that include a growth factor binding domain. The peptides described in this patent have an amino acid sequence that is at least 80% identical to specific sequences, and they are designed to be less than 300 amino acids in length. Another significant patent is "Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen." This invention focuses on methods and compositions that evoke protective immune responses against infections or cancer, utilizing a lymphangiogenesis inducer and an antigen.

Career Highlights

Priscilla has worked with prestigious institutions such as the University of Chicago and Imperial College Innovations Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas.

Collaborations

Throughout her career, Priscilla has collaborated with esteemed colleagues, including Jeffrey Alan Hubbell and Anna M Randi. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Priscilla S Briquez is a pioneering inventor whose work in wound treatment and melanoma research has the potential to make a significant impact in the medical field. Her innovative patents reflect her dedication to addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…